Cholesterol uptake capacity: A new measure of high-density lipoprotein functionality as a predictor of subsequent revascularization in patients undergoing percutaneous coronary intervention
- 24 January 2022
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 345, 44-50
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosisNature Medicine, 2013
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary SyndromeNew England Journal of Medicine, 2012
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation studyThe Lancet, 2012
- High Density Lipoprotein and it’s DysfunctionThe Open Biochemistry Journal, 2012
- PredictABEL: an R package for the assessment of risk prediction modelsEuropean Journal of Epidemiology, 2011
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and AtherosclerosisNew England Journal of Medicine, 2011
- Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterolJournal of Lipid Research, 2010
- Increased Inflammatory Gene Expression in ABC Transporter–Deficient MacrophagesCirculation, 2008
- Beyond High-Density Lipoprotein Cholesterol LevelsJACC, 2008
- Effects of Torcetrapib in Patients at High Risk for Coronary EventsNew England Journal of Medicine, 2007